Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase EARLY_PHASE1 1Phase 4 1Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1Metabolic Syndrome 1

Interventions

fludarabine 17Cyclophosphamide 16Positron Emission Tomography Computed Tomography 4Oncolytic Virotherapy 4Metformin 468Ga-pentixafor 4lenvatinib 3Radiosurgery 3Pemetrexed 3Paclitaxel 3Melphalan 3Immunotherapy, Adoptive 3Gemcitabine 3Cholestanetriol 26-Monooxygenase 3Carboplatin 3toripalimab 2sintilimab 2pembrolizumab 2gallium Ga 68 dotatate 2gallium 68 PSMA-11 2fludarabine phosphate 2alpha-Synuclein 2Progesterone 2Nivolumab 2Neoadjuvant Therapy 2Magnetic Resonance Spectroscopy 2Interleukin-2 2Influenza Vaccines 2Fluorodeoxyglucose F18 2Ethiodized Oil 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Unknown × Inositol × Clear all
NCT01574261 2012-04-10

Could the Therapy With Inositol Affect the Cardiovascular Risk in PCOS Women? Results of a Randomized Clinical Trial

Catholic University of the Sacred Heart

Phase EARLY_PHASE1 Unknown
70 enrolled

Polycystic Ovary Syndrome, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡